IMMG — Immage Biotherapeutics Balance Sheet
0.000.00%
Basic MaterialsHighly SpeculativeMicro Cap
Annual balance sheet for Immage Biotherapeutics, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2012 September 30th | 2013 September 30th | 2014 September 30th | 2015 August 31st | 2016 August 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.005 | 0.007 | 0.002 | 0.033 | 0.197 |
Prepaid Expenses | |||||
Total Current Assets | 0.005 | 0.007 | 0.002 | 0.034 | 0.205 |
Net Property, Plant And Equipment | — | — | — | 0.04 | 0.032 |
Net Intangible Assets | |||||
Total Assets | 0.005 | 0.007 | 0.002 | 0.08 | 0.243 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.007 | 0.016 | 0.024 | 0.051 | 0.056 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.007 | 0.016 | 0.024 | 0.051 | 0.056 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.002 | -0.009 | -0.022 | 0.029 | 0.187 |
Total Liabilities & Shareholders' Equity | 0.005 | 0.007 | 0.002 | 0.08 | 0.243 |
Total Common Shares Outstanding |